Orient EuroPharma Co., Ltd. (TPEX:4120)

Orient EuroPharma Revenue

Orient EuroPharma had revenue of 1.15B TWD in the quarter ending March 31, 2026, a decrease of -0.46%. This brings the company's revenue in the last twelve months to 4.59B, up 3.30% year-over-year. In the year 2025, Orient EuroPharma had annual revenue of 4.60B with 4.64% growth.

• Revenue (ttm): 4.59B
• Revenue Growth: +3.30%
• P/S Ratio: 0.84
• Revenue / Employee: 13.54M
• Employees: 339
• Market Cap: 3.87B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	4.60B	203.80M	4.64%
Dec 31, 2024	4.39B	-200.59M	-4.37%
Dec 31, 2023	4.59B	-138.56M	-2.93%
Dec 31, 2022	4.73B	-36.57M	-0.77%
Dec 31, 2021	4.77B	-616.63M	-11.45%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 30, 2026

Data Sources Report a data error